CUSIP 45254E107CLASS A COMIMRXQ4 2025
31 filings · latest Jan 22, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 9.69M | $63.73M |
| 2 | Sanofi | 2.71M | $17.82M |
| 3 | Empery Asset Management, LP | 2.67M | $17.60M |
| 4 | Vanguard Group Inc | 2.57M | $16.90M |
| 5 | State Street Corp | 2.40M | $15.81M |
| 6 | Blackrock, Inc. | 1.45M | $9.55M |
| 7 | Marshall Wace, LLP | 711.9K | $4.68M |
| 8 | Blue Owl Capital Holdings LP | 665.0K | $4.38M |
| 9 | Geode Capital Management, LLC |
| 4 | Oct 7, 2025 | Fmr LLC | 13G | 14.5% | 8.79M | SEC |
| 5 | Oct 3, 2025 | Hbm Healthcare Investments (Cayman) Ltd. | 13G | 5.7% | 3.65M | SEC |
| 6 | Jan 17, 2025 | Benjamin J. Zeskind | 13G/A | 12.8% | 3.98M | SEC |
| 7 | Nov 14, 2024 | Cormorant Asset Management, LP | 13G/A | — | — | SEC |
| 8 | Nov 14, 2024 | Citadel Advisors LLC | 13G/A | — | — | SEC |
| 9 | Apr 15, 2024 | Cormorant Asset Management, LP | 13G/A | 1.9% | 561.1K | SEC |
| 10 | Apr 10, 2024 | Price T Rowe Associates Inc /Md/ | 13G/A | 3.1% | 910.3K | SEC |
See the full Schedule 13D/13G history for Immuneering Corp.
Unlock full history| 618.1K |
| $4.07M |
| 10 | Occam Crest Management LP | 498.5K | $3.28M |